PATIENT-REPORTED EXPERIENCES WITH SELF-INJECTIONS USING PREFILLED SYRINGE AND AUTOINJECTOR DEVICES IN AN OPEN-LABEL, LONG-TERM STUDY OF GALCANEZUMAB IN PATIENTS WITH MIGRAINE

被引：0
|
作者：
Stauffer, V. L. [1 ]
Sides, R. [1 ]
Lanteri-Minet, M. [2 ]
Kielbasa, W. [1 ]
Jin, Y. [1 ]
Selzler, K. J. [1 ]
Tepper, S. J. [3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Ctr Hosp Univ Nice, Nice, France
[3] Geisel Sch Med Dartmouth, Hanover, NH USA
来源：
CEPHALALGIA | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [41] Zanaflex® treatment of spasticity in patients with multiple sclerosis:: A long-term, open-label study
    Stazio, A
    Groves, L
    Hudson, S
    NEUROLOGY, 1998, 50 (04) : A147 - A147
  • [42] An Open-Label Long-Term Naturalistic Study of Mirtazapine Treatment for Depression in Cancer Patients
    Mehmet A. Ersoy
    Aysin M. Noyan
    Hayriye Elbi
    Clinical Drug Investigation, 2008, 28 : 113 - 120
  • [43] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial
    Ashina, Messoud
    Roos, Caroline
    Li, Lily Qian
    Komori, Mika
    Ayer, David
    Ruff, Dustin
    Krege, John Henry
    CEPHALALGIA, 2023, 43 (04)
  • [44] An open-label study to evaluate the long-term safety of zelrix™, a sumatriptan iontophoretic patch for the treatment of acute migraine
    Smith, T.
    Pierce, M.
    Griesser, J.
    Sebree, T.
    O'Neill, C.
    CEPHALALGIA, 2011, 31 (01) : 120 - 120
  • [45] Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents
    Berenson, Frank
    Vasconcellos, Elza
    Pakalnis, Ann
    Mao, Lian
    Biondi, David M.
    Armstrong, Robert B.
    HEADACHE, 2010, 50 (05): : 795 - 807
  • [46] Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
    True, David
    Mullin, Kathleen
    Croop, Robert
    PAIN AND THERAPY, 2024, 13 (05) : 1203 - 1218
  • [47] Long-Term Patient-Reported Outcomes From an Open-Label Safety and Efficacy Study of Bosutinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Patients Resistant or Intolerant to Prior Therapy
    Kantarjian, Hagop M.
    Mamolo, Carla M.
    Gambacorti-Passerini, Carlo
    Cortes, Jorge E.
    Bruemmendorf, Tim H.
    Su, Yun
    Reisman, Arlene L.
    Shapiro, Mark
    Lipton, Jeff H.
    CANCER, 2018, 124 (03) : 587 - 595
  • [48] SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Chou, Denise E.
    Lima, Gabriel Paiva da Silva
    CEPHALALGIA, 2020, 40 : 60 - 61
  • [49] Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan Lewis
    Dolezil, David
    Silberstein, Stephen D.
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    CEPHALALGIA, 2020, 40 (06) : 543 - 553
  • [50] Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension
    Chen, Michelle Y.
    Sall, Kenneth N.
    Tepedino, Michael
    McLaurin, Eugene
    Olander, Kenneth
    Wirta, David
    Flynn, William
    Walker, Gary
    Ling, Jill
    Yang, Jingyuan
    Goodkin, Margot
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345